Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: DOAC

Head-to-head: post-TAVR edoxaban not better than DAPT

Presented By
Prof. Duk-Woo Park, Asan Medical Center, Korea
Trial
Phase 4, ADAPT-TAVR
Conference
ACC 2022

15 June, 2022 14:09

2021 ESC/EACTS Guidelines on Valvular Heart Disease

Presented By
Dr Victoria Delgado, Leiden University Medical Center, the Netherlands
Conference
ESC 2021

26 October, 2021 12:18

DOACs and bleeding: the role of antidotes

Presented By
Dr Kaveshree Govender, Milpark Hospital, South Africa
Trial
RE-VERSE AD
Conference
EHRA 2021

16 June, 2021 10:26

2021 EHRA practical guide: DOACs in pre-operative and bleeding patients

Presented By
Prof. Thomas Vanassche, University Hospitals Leuven, Belgium
Conference
EHRA 2021

15 June, 2021 15:37

Surgical bleeding risk most important determinant of bleeding outcomes

Presented By
Dr Kira MacDougall, Staten Island University Hospital, USA
Trial
PAUSE
Conference
ISTH 2020

8 September, 2020 16:27

Similar bleeding rates in patients with VTE and AF treated with DOACs

Presented By
Dr Farès Moustafa, CHU Clermont Ferrand, France
Conference
ISTH 2020

8 September, 2020 16:21

Finding the sweet spot of anticoagulation in AF patients with ACS

Presented By
Prof. Renato D. Lopes, Duke University School of Medicine, USA
Trial
AUGUSTUS
Conference
ISTH 2020

8 September, 2020 14:59

Lower embryopathy risk with DOAC versus VKA during pregnancy

Presented By
Dr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany
Conference
ISTH 2020

8 September, 2020 14:53

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By
Dr G.R. Hong, Yonsei University College of Medicine, South Korea
Trial
ENAVLE
Conference
ACC 2020

7 September, 2020 23:15

Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel

Presented By
Dr V. Nijenhuis, St. Antonius Hospital, the Netherlands
Trial
POPular-TAVI
Conference
ACC 2020

7 September, 2020 23:14

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By
Prof. G. Agnelli, University of Perugia, Italy
Trial
Phase 3, CARAVAGGIO
Conference
ACC 2020

7 September, 2020 23:13

Aspirin plus DOAC is not better than a DOAC alone

Presented By
Prof. Jordan Schaefer, University of Michigan, USA
Conference
ASH 2019

5 March, 2020 19:23

Haematoma expansion and mortality in intracerebral haemorrhage after OAC

Conference
EAN 2019

27 August, 2019 12:54

Lower rates stroke/SE with DOACs in frail non-valvular AF patients

Presented By
Prof. Gregory Lip, University of Birmingham, United Kingdom
Conference
ACC 2019

6 June, 2019 15:50

Similar rates of stroke/SE associated with DOAC vs warfarin use in obese non-valvular AF patients: Results from an observational registry

Presented By
Dr Steven Deitelzweig, Ochsner Health System, USA
Conference
ACC 2019

6 June, 2019 14:55

Substantial impact of temporary interruptions of warfarin versus DOAC

Presented By
Dr Malini Madhavan, Mayo Clinic, USA
Trial
ORBIT-AF
Conference
ACC 2019

4 June, 2019 14:17

Less bleeding and fewer hospitalisations with antithrombotic regimen with apixaban without aspirin

Trial
AUGUSTUS
Conference
ACC 2019

4 June, 2019 13:19
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy